Intrinsic Value of S&P & Nasdaq Contact Us

Radient Technologies Inc. RDDTF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
43/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Radient Technologies Inc. (RDDTF) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 40/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
43/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
15/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — RDDTF

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2014 $-22.07 $181.09K $-5.32M -2940.5%
2015 $-0.45 $131.41K $-14.14M -10758.7%
2016 $-0.09 $626.46K $-4.37M -697%
2017 $-0.05 $293.45K $-4.32M -1470.9%
2018 $-0.07 $455.83K $-14.05M -3081.9%
2019 $-0.11 $214.06K $-27.86M -13013%
2020 $-0.14 $18.4M $-37.42M -203.3%
2021 $-0.13 $2.49M $-42.27M -1697.8%
2022 $-0.03 $3.62M $-12.93M -357%
2023 $0.00 $0.00 $0.00 -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message